These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34379293)

  • 1. Targeting Complement C3a Receptor to Improve Outcome After Ischemic Brain Injury.
    Pekna M; Stokowska A; Pekny M
    Neurochem Res; 2021 Oct; 46(10):2626-2637. PubMed ID: 34379293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement C3a treatment accelerates recovery after stroke via modulation of astrocyte reactivity and cortical connectivity.
    Stokowska A; Aswendt M; Zucha D; Lohmann S; Wieters F; Morán Suarez J; Atkins AL; Li Y; Miteva M; Lewin J; Wiedermann D; Diedenhofen M; Torinsson Naluai Å; Abaffy P; Valihrach L; Kubista M; Hoehn M; Pekny M; Pekna M
    J Clin Invest; 2023 May; 133(10):. PubMed ID: 36995772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3a Receptor Signaling Inhibits Neurodegeneration Induced by Neonatal Hypoxic-Ischemic Brain Injury.
    Pozo-Rodrigálvarez A; Li Y; Stokowska A; Wu J; Dehm V; Sourkova H; Steinbusch H; Mallard C; Hagberg H; Pekny M; Pekna M
    Front Immunol; 2021; 12():768198. PubMed ID: 34975856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement inhibition promotes endogenous neurogenesis and sustained anti-inflammatory neuroprotection following reperfused stroke.
    Ducruet AF; Zacharia BE; Sosunov SA; Gigante PR; Yeh ML; Gorski JW; Otten ML; Hwang RY; DeRosa PA; Hickman ZL; Sergot P; Connolly ES
    PLoS One; 2012; 7(6):e38664. PubMed ID: 22761695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Complement C3a Receptor in Stroke.
    Ahmad S; Bhatia K; Kindelin A; Ducruet AF
    Neuromolecular Med; 2019 Dec; 21(4):467-473. PubMed ID: 31102134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor for complement peptide C3a: a therapeutic target for neonatal hypoxic-ischemic brain injury.
    Järlestedt K; Rousset CI; Ståhlberg A; Sourkova H; Atkins AL; Thornton C; Barnum SR; Wetsel RA; Dragunow M; Pekny M; Mallard C; Hagberg H; Pekna M
    FASEB J; 2013 Sep; 27(9):3797-804. PubMed ID: 23737250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury.
    Wang Y; Li Y; Dalle Lucca SL; Simovic M; Tsokos GC; Dalle Lucca JJ
    J Neuroinflammation; 2010 Apr; 7():24. PubMed ID: 20380727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement peptide C3a stimulates neural plasticity after experimental brain ischaemia.
    Stokowska A; Atkins AL; Morán J; Pekny T; Bulmer L; Pascoe MC; Barnum SR; Wetsel RA; Nilsson JA; Dragunow M; Pekna M
    Brain; 2017 Feb; 140(2):353-369. PubMed ID: 27956400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement: a novel factor in basal and ischemia-induced neurogenesis.
    Rahpeymai Y; Hietala MA; Wilhelmsson U; Fotheringham A; Davies I; Nilsson AK; Zwirner J; Wetsel RA; Gerard C; Pekny M; Pekna M
    EMBO J; 2006 Mar; 25(6):1364-74. PubMed ID: 16498410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent.
    Ducruet AF; Hassid BG; Mack WJ; Sosunov SA; Otten ML; Fusco DJ; Hickman ZL; Kim GH; Komotar RJ; Mocco J; Connolly ES
    J Cereb Blood Flow Metab; 2008 May; 28(5):1048-58. PubMed ID: 18197178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic hypothermia modulates complement factor C3a and C5a levels in a rat model of hypoxic ischemic encephalopathy.
    Shah TA; Nejad JE; Pallera HK; Lattanzio FA; Farhat R; Kumar PS; Hair PS; Bass WT; Krishna NK
    Pediatr Res; 2017 Apr; 81(4):654-662. PubMed ID: 28002390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation sustains neuroinflammation and deteriorates adult neurogenesis and spatial memory impairment in rat hippocampus following sleep deprivation.
    Wadhwa M; Prabhakar A; Anand JP; Ray K; Prasad D; Kumar B; Panjwani U
    Brain Behav Immun; 2019 Nov; 82():129-144. PubMed ID: 31408672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement C3a binding to its receptor as a negative modulator of Th2 response in liver injury in trichloroethylene-sensitized mice.
    Wang F; Zha WS; Zhang JX; Li SL; Wang H; Ye LP; Shen T; Wu CH; Zhu QX
    Toxicol Lett; 2014 Aug; 229(1):229-39. PubMed ID: 24974766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal C3a treatment ameliorates cognitive impairment in a mouse model of neonatal hypoxic-ischemic brain injury.
    Morán J; Stokowska A; Walker FR; Mallard C; Hagberg H; Pekna M
    Exp Neurol; 2017 Apr; 290():74-84. PubMed ID: 28062175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement C3a enhances CXCL12 (SDF-1)-mediated chemotaxis of bone marrow hematopoietic cells independently of C3a receptor.
    Honczarenko M; Ratajczak MZ; Nicholson-Weller A; Silberstein LE
    J Immunol; 2005 Sep; 175(6):3698-706. PubMed ID: 16148115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective engraftment of C3aR-/- hematopoietic stem progenitor cells shows a novel role of the C3a-C3aR axis in bone marrow homing.
    Wysoczynski M; Reca R; Lee H; Wu W; Ratajczak J; Ratajczak MZ
    Leukemia; 2009 Aug; 23(8):1455-61. PubMed ID: 19357704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement Peptide C3a Promotes Astrocyte Survival in Response to Ischemic Stress.
    Shinjyo N; de Pablo Y; Pekny M; Pekna M
    Mol Neurobiol; 2016 Jul; 53(5):3076-3087. PubMed ID: 25972241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The three-phase enriched environment paradigm promotes neurovascular restorative and prevents learning impairment after ischemic stroke in rats.
    Zhan Y; Li MZ; Yang L; Feng XF; Lei JF; Zhang N; Zhao YY; Zhao H
    Neurobiol Dis; 2020 Dec; 146():105091. PubMed ID: 32979506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracortical Administration of the Complement C3 Receptor Antagonist Trifluoroacetate Modulates Microglia Reaction after Brain Injury.
    Surugiu R; Catalin B; Dumbrava D; Gresita A; Olaru DG; Hermann DM; Popa-Wagner A
    Neural Plast; 2019; 2019():1071036. PubMed ID: 31814819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis.
    Boos L; Campbell IL; Ames R; Wetsel RA; Barnum SR
    J Immunol; 2004 Oct; 173(7):4708-14. PubMed ID: 15383607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.